MENU
JUN 20, 2019 10:30 AM PDT

Outlier Kinases as Targets for Precision Therapy

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Research Assistant Professor of Urology, Northwestern University, Feinberg School of Medicine
    Biography
      The overall theme of my research is to identify, characterize and target the genes that help in the progression of aggressive prostate cancers. During my postdoctoral fellowship, I developed novel approaches to identify outlier kinases in breast and pancreatic cancer and studied the role of these kinases in oncogenic progression. I continued to apply this novel matrix to identify novel biomarkers to distinguish indolent from aggressive prostate cancer and to interrogate therapeutic targets in advanced prostate cancer. Apart from identifying biomarkers and therapeutic targets, I also have an expertise in delineating oncogenic signaling and resistance mechanisms and carry out translational research. My goal is to delineate the molecular and biological differences between the prostate cancers in African-American and Caucasian men, to help progress the field towards personalized medicine.

    Abstract

    In this presentation, Dr. Kothari will provide an overview of the Precision Medicine Initiative from NIH and how NGS technologies have helped the researchers to look deep inside the human transcriptome. Focusing on kinases, Dr. Kothari will discuss the sample centric versus gene centric approaches to analyze the transcriptome data to identify new drug targets. He will finally share his thoughts on how integrative omics approaches can help researchers find better drug targets and robust biomarkers of disease progression, that will help in achieving the goals of precision medicine initiative. 

    Learning Objectives: 

    1. To understand the merit of sample centric transcriptome analysis to identify new drug targets using NGS.
    2. To understand the merit of gene centric transcriptome analysis to identify new drug targets using nGS.
     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    Loading Comments...
    Show Resources